About
EXORPHIA develops extracellular vesicle (EV) technologies to enhance embryo quality and improve success rates in in vitro fertilization (IVF), as well as pioneering exosome-based drug discovery for difficult-to-treat diseases.
Explore EXORPHIA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.